VitriVax: Funding, Investors & Team (Oct 2026)
VitriVax, a biotech startup based in Boulder, Colorado, specializes in creating a platform for vaccine formulation. The company has developed a unique technology, which was constructed at the University of Colorado with significant funding from NIH, NSF, the State of Colorado, and most recently, the Bill and Melinda Gates Foundation, totaling over $7.2M. This innovative technology aims to enhance the efficiency, affordability, and global accessibility of vaccines for both humans and animals.
VitriVax has raised $25.9M across 3 funding rounds on record, the most recent a Series B of $17.3M announced in Oct 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
VitriVax Company Profile and Key Stats
Latest funding round on record: Oct 2025.
VitriVax Funding Rounds
VitriVax raised $5.0M in an undisclosed round announced in Dec 2023.
1 years later, an undisclosed round of $3.6M was announced in Dec 2024.
10 months later, a Series B of $17.3M was announced in Oct 2025.
VitriVax Founders and Leadership Team
No contact details are on record for this team yet.
VitriVax Funding Compared to Other Biotechnology Startups
VitriVax's latest round of $17.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VitriVax in Biotechnology and Boulder
Companies Similar to VitriVax
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
VitriVax Funding FAQs
What does VitriVax do?
VitriVax, a biotech startup based in Boulder, Colorado, specializes in creating a platform for vaccine formulation. The company has developed a unique technology, which was constructed at the University of Colorado with significant funding from NIH, NSF, the State of Colorado, and most recently, the Bill and Melinda Gates Foundation, totaling over $7.2M. This innovative technology aims to enhance the efficiency, affordability, and global accessibility of vaccines for both humans and animals.
How much funding has VitriVax raised?
VitriVax has raised $25.9M across 3 rounds on record. The most recent is a Series B of $17.3M announced in Oct 2025.
When did VitriVax last raise funding?
VitriVax's most recent funding round on record is a Series B of $17.3M, announced in Oct 2025.
Who founded VitriVax?
FundedIQ lists Bryan S (Founder), Robert Garcea (Founder) at VitriVax.
Where is VitriVax headquartered?
VitriVax is based in Boulder, Colorado, United States.
How many employees does VitriVax have?
VitriVax is in the 11-50 employee band.
How does VitriVax's funding compare to other Biotechnology startups?
VitriVax's latest round of $17.3M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's VitriVax Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VitriVax is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.